Inventor
Gang Chen
Inventor
Yorktown Heights, NY, US
Overview
Patents· 132 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
A61KPreparations for medical, dental or toiletry purposes14%
C12NMicroorganisms or enzymes9%
C07DHeterocyclic compounds6%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture6%
C12YEnzymes3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C07HSugars2%
C09JAdhesives2%
PatentTitleYear
10,875,907Filovirus antibody202010,876,257Water-induced anti-counterfeiting paper and preparation method thereof202010,836,821Drug-conjugates with a targeting molecule and two different drugs202010,821,196Substrate based PET imaging agents202010,787,501Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments202010,787,754Polymer/filler/metal composite fiber and preparation method thereof202010,766,880Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators202010,752,698Method for generating high affinity antibodies202010,717,749Macrocyclic sulfondiimine compounds202010,696,973Inducible eukaryotic expression system202010,633,375Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereof202010,611,831Production cell line enhancers202010,598,669Isolating cells expressing secreted proteins202010,590,165Antibody drug conjugates202010,584,173Nucleic acids encoding high affinity antibodies to human IL-6 receptor202010,472,323Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof201910,457,959Efficient selectivity of recombinant proteins201910,435,461Therapy for filovirus infection201910,428,135Fusion polypeptides capable of activating receptors201910,415,055Enhanced expression and stability regions201910,400,000Amide-linked EP4 agonist-bisphosphonate compounds and uses thereof201910,351,622Production cell line enhancers201910,261,093Isolating cells expressing secreted proteins201910,239,851Carboxylic acid derivatives and use thereof in the preparation of prodrugs201910,233,173Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators201910,227,401Production cell line enhancers201910,099,932Rapid synthesis method of small-crystal-grain ZSM-5 molecular sieve201810,099,931One-step preparation method for hollow shell type small grain ZSM-5 molecular sieve201810,081,669Therapy for filovirus infection201810,071,988Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators201810,028,914Reduction type coenzyme Q10 powder, composition thereof, and preparation method thereof201810,011,632PSMA imaging agents201810,006,070Fucosylation-deficient cells20189,963,464Macrocyclic compounds20189,944,934Inducible eukaryotic expression system20189,932,605Enhanced expression and stability regions20189,884,916'High affinity antibodies to human IL-6 receptor'20189,840,549'Fusion polypeptides capable of activating receptors'20179,816,110'CHO integration sites and uses thereof'20179,808,912'Method for fabricating super mirror finish stainless steel decorative sheet'20179,758,592'Recombinant cell surface capture proteins'20179,732,357'Efficient selectivity of recombinant proteins'20179,724,374'Capsule containing total flavonoids of desmodium styracifolium, method for preparing the same and use'20179,688,751'Production cell line enhancers'20179,650,414'Dual-action EP4 agonist—bisphosphonate conjugates and uses thereof'20179,650,390'Water-soluble taxane derivatives and uses thereof'20179,643,917'Water-soluble propofol derivatives and uses thereof'20179,611,262'Substituted 2-azabicycles and their use as orexin receptor modulators'20179,567,300'Hexahydropentaleno derivatives, preparation method and use in medicine thereof'20179,562,238'Enhanced expression and stability regions'20179,550,823'Fucosylation-deficient cells'20179,469,856'Inducible eukaryotic expression system'20169,394,329'Glucopyranosyl derivatives and their uses in medicine'20169,389,236'Isolating cells expressing secreted proteins'20169,382,315'Production cell line enhancers'20169,346,875'Therapy for filovirus infection'20169,308,256'Method of treating rheumatoid arthritis with an anti-IL-6R antibody'20169,239,324'Antibody-binding protein-drug conjugate and methods of use'20169,228,012'Production cell line enhancers'20169,227,223'Method for preparing the matte anti-fingerprint stainless steel decorative plate'20169,222,106'Enhanced expression and stability regions'20159,206,455'Fucosylation-deficient cells'20159,206,252'Pharmaceutical compositions comprising IL-1B binding antibodies and fragments thereof'20159,193,786'Production cell line enhancers'20159,120,851'Human antibodies to human angiopoietin-like protein 4'20159,079,954'Production cell line enhancers'20159,023,318'Compounds with matrix-metalloproteinase inhibitory activity and imaging agents thereof'20159,005,577'Substrate based PET imaging agents'20158,937,048'Anti-angiogenic compounds'20158,932,557'Imaging agents for detecting neurological dysfunction'20158,927,233'Fusion polypeptides capable of activating receptors'20158,865,430'Fusion polypeptides capable of activating receptors'20148,673,589'Inducible eukaryotic expression system'20148,597,898'Fusion polypeptides capable of activating receptors'20138,580,763'2, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof'20138,568,721'Method of treating rheumatoid arthritis with an anti-IL-6R antibody'20138,491,869'Imaging agents for detecting neurological disorders'20138,486,372'Cyclic azapeptides as integrin markers and methods of using'20138,470,324'Fusion polypeptides capable of activating receptors'20138,420,052'Imaging agents useful for identifying AD pathology'20138,409,838'Fucosylation-deficient cells'20138,389,239'Enhanced expression and stability regions'20138,377,442'Method of treating inflammatory eye disease with IL-1β binding antibodies'20138,354,103'Human antibodies to human angiopoietin-like protein 4'20138,354,092'Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry'20138,318,132'Imaging agents for detecting neurological dysfunction'20128,298,532'Fusion polypeptides capable of activating receptors'20128,293,714'Anti-angiogenic compounds'20128,293,206'Achievement of a high therapeutic index through molecular imaging guided targeted drug treatment'20128,192,741'Method of treating rheumatoid arthritis with an anti-IL-6R antibody'20128,183,014'High affinity antibodies to human IL-6 receptor'20128,080,248'Method of treating rheumatoid arthritis with an IL-6R antibody'20118,043,601'Cyclic azapeptides as integrin markers'20118,043,617'Human antibodies to human IL-6 receptor'20117,988,968'Method of treating an IL-1 related coronary condition'20117,943,121'IL-1β binding antibodies and fragments thereof'20117,871,796'Isolation of binding proteins with high affinity to ligands'20117,863,293'CXCR4 chemokine receptor binding compounds'20117,847,364'Flexible photo-detectors'20107,829,094'Method of treating an IL-1 related cancer'20107,829,063'Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry'20107,829,093'Method of treating an IL-1 related autoimmune disease or condition'20107,771,997'Enhanced expression and stability regions'20107,744,865'IL1-β Binding antibodies and fragments thereof'20107,744,866'IL-1β binding antibodies and binding fragments thereof'20107,723,525'Chemokine-binding heterocyclic compound salts, and methods of use thereof'20107,695,717'Method of treating an IL-1 related inflammatory disease or condition'20107,655,312'Two-part polyurethane adhesives for structural finger joints and method therefor'20107,582,298'High affinity antibodies to human IL-6 receptor'20097,582,742'Method of treating or preventing an IL-1 related disease or condition'20097,570,864'Polymeric compositions comprising quantum dots, optical devices comprising these compositions and methods for preparing same'20097,550,484'Chemokine receptor binding heterocyclic compounds with enhanced efficacy'20097,534,604'Fusion polypeptides capable of activating receptors'20097,531,166'IL-1β binding antibodies and fragments thereof'20097,501,518'Methods of making 2,6-diaryl piperidine derivatives'20097,457,508'Polymeric compositions comprising quantum dots, optical devices comprising these compositions and methods for preparing same'20087,435,553'Isolating cells expressing secreted proteins'20087,419,724'Two-part polyurethane adhesives for structural finger joints and method therefor'20087,332,605'Process for the synthesis of CXCR4 antagonist'20087,291,631'CXCR4 chemokine receptor binding compounds'20077,197,226'Polymeric compositions comprising quantum dots, optical devices comprising these compositions and methods for preparing same'20077,168,266'Process for making crystalline structures having interconnected pores and high refractive index contrasts'20077,083,945'Isolation of binding proteins with high affinity to ligands'20067,071,248'Adhesive additives and adhesive compositions containing an adhesive additive'20067,065,285'Polymeric compositions comprising quantum dots, optical devices comprising these compositions and methods for preparing same'20066,987,020'Full-gene sequence of the donkey leukocyte vaccine strain of the equine infectious anemia virus and their application'20066,919,183'Isolating cells expressing secreted proteins'20056,632,873'Two-part polyurethane adhesives for structural finger joints and method therefor'20036,365,650'Heat and radio frequency-curable two-pack soy protein-based polyurethane adhesive compositions'20026,231,985'Heat and radio frequency-curable two-pack soy protein-based polyurethane adhesive compositions'20015,830,697'P-glycoprotein mutant resistant to cyclosporin modulation'19985,434,213'Pressure sensitive adhesive with enhanced adhesion to low surface energy substrates'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2010Based in Dublin, OH, US· patent location history
2005–2020Patents assigned to REGENERON PHARMA (52)· patent assignee history
2005–2020Based in Yorktown Heights, NY, US· patent location history
2007–2019Based in Langley, CA· patent location history
2009–2015Patents assigned to XOMA TECHNOLOGY LTD (11)· patent assignee history
2009–2020Based in San Diego, CA, US· patent location history
2010–2015Based in Los Angeles, CA, US· patent location history
2011–2018Patents assigned to CHEN GANG (24)· patent assignee history
2012–2018Patents assigned to KASI DHANALAKSHMI (10)· patent assignee history
2012–2018Patents assigned to MOCHARLA VANI P (9)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 52 | 2005–2020 |
| CHEN GANGself | 24 | 2011–2018 |
| XOMA TECHNOLOGY LTD | 11 | 2009–2015 |
| KASI DHANALAKSHMI | 10 | 2012–2018 |
| MOCHARLA VANI P | 9 | 2012–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Yorktown Heights, New York, US | 52 | 2005–2020 |
| San Diego, California, US | 21 | 2009–2020 |
| Los Angeles, California, US | 8 | 2010–2015 |
| Langley, CA | 7 | 2007–2019 |
| Dublin, OH, US | 6 | 2001–2010 |